Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.

about

The MYCN Protein in Health and Disease.MYCN-targeting vaccines and immunotherapeutics.Emerging and investigational therapies for neuroblastoma.Trial watch: DNA-based vaccines for oncological indications

P2860

Q39208675-F66AB6E7-0C9B-410F-B83F-72E7C72C66A7 Q41118615-FC166761-A517-4185-AD5A-F2ABA9C0FFBA Q50073387-A6344710-E8EF-414A-85F5-6E040D59C5D3 Q56893452-7DF2A31E-CB35-40C2-9255-F1B048F8E787

P2860

Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.

Item

http://www.wikidata.org/entity/Q38863894

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.

@en

type

Item

label

Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.

@en

prefLabel

Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.

@en

P1476

Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice

@en

P2093

Alexander Schramm

http://www.w3.org/2001/XMLSchema#string

Alexander Stermann

http://www.w3.org/2001/XMLSchema#string

Angelika Eggert

http://www.w3.org/2001/XMLSchema#string

Diana Seidel

http://www.w3.org/2001/XMLSchema#string

Georg Eschenburg

http://www.w3.org/2001/XMLSchema#string

Michael Stauder

http://www.w3.org/2001/XMLSchema#string

Nicole Huebener

http://www.w3.org/2001/XMLSchema#string

Stefan Fest

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for the activation of 20S proteasomes by 11S regulators

SYFPEITHI: database for MHC ligands and peptide motifs

Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization.

CD4 T cells in tumor immunity.

The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design.

An innate sense of danger.

DNA minigene vaccination for adjuvant neuroblastoma therapy.

Promising therapeutic targets in neuroblastoma

Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing.

Characterization of antigen-presenting properties of tumour cells using virus-specific cytotoxic T lymphocytes

P2888

s00262-015-1733-1

P304

1215-1227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-015-1733-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Holger Lode

P577

2015-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278592851

http://www.w3.org/2001/XMLSchema#string

P6179

1050861726

http://www.w3.org/2001/XMLSchema#string

P698

26076666

http://www.w3.org/2001/XMLSchema#string

Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.

about

P2860

P2860

Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698